Breast cancer is the leading cause of cancer death in women worldwide,and metastasis-related recurrence accounts for over 90%of treatment failure clinically.Co-delivery of microRNAs(miRNAs)and chemotherapeutics into tumor cells is an attractive strategy for synergistic breast cancer therapy through their different anticancer mechanism.